e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Treatment strategies, systemic manifestations and biomarkers in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airway resistance and reactance in COPD patients and healthy smokers, and effect of bronchodilators
L. Svensson, J. Ankerst, L. Bjermer, E. Tufvesson (Lund, Sweden)
Source:
Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Session:
Treatment strategies, systemic manifestations and biomarkers in airway diseases
Session type:
Thematic Poster Session
Number:
4053
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Svensson, J. Ankerst, L. Bjermer, E. Tufvesson (Lund, Sweden). Airway resistance and reactance in COPD patients and healthy smokers, and effect of bronchodilators. Eur Respir J 2011; 38: Suppl. 55, 4053
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Airway resistance variability and response to bronchodilator in children with asthma
Source: Eur Respir J 2007; 30: 260-268
Year: 2007
Airway pathology in COPD compared to that in smokers with asthma
Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities
Year: 2008
Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD
Source: International Congress 2016 – Non-inflammatory COPD monitoring
Year: 2016
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV
1
and FEV
1
in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005
Airway resistance correlates with the frequency of exacerbation in patient with COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Airway resistances deteriorate following spirometry in asthma and COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Ventilation heterogeneity in COPD and healthy smokers relates to diffusion capacity, resistance and reactance
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Influence of smoking on airway and systemic inflammation in healthy subjects and COPD patients
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Smoking, sputum cell counts, diffusion capacity and hyperinflation predict beneficial effects of long-term inhaled corticosteroids (ICS) on FEV1-decline in patients with mild-to-moderate COPD
Source: Annual Congress 2010 - COPD: management
Year: 2010
Postbronchodilator response of small airways after 800 microgrammes of salbutamol in COPD patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Airway resistance in COPD
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012
How the bronchodilatator in COPD patients works
Source: Eur Respir J 2004; 24: Suppl. 48, 288s
Year: 2004
Restoring corticosteroid sensitivity in COPD and smokers with asthma
Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities
Year: 2008
Effects of tiotropium on lung function in current smokers and never smokers with asthma
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
COPD and airway responsiveness to beta-agonists
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III
Year: 2007
Adhesion to inhaled treatment in patients with asthma and COPD
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Dynamic compliance and reactance in older non-smokers with asthma and fixed airflow obstruction
Source: Eur Respir J, 58 (2) 2004400; 10.1183/13993003.04400-2020
Year: 2021
Airway calibre variability by forced oscillation technique: a sensitive indicator of bronchodilator effect in asthmatic children
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept